News
News releases on January 4, 2023, page 3
Every news release public companies put out on January 4, 2023 (UTC): 359 news releases, newest first. Open any release to read it.
Personalis Reports Preliminary Fourth Quarter and Full Year 2022 Revenue
Personalis, Inc. · Jan 4, 2023
Perion’s Momentum Extends into the Fourth Quarter of 2022 – Preliminary Results Show Over 60% YoY Adjusted EBITDA Growth and 30% YoY Reve...
Perion Network Ltd · Jan 4, 2023
Patterson-UTI Energy Provides Update on Expected Fourth Quarter Financial Results
Patterson-UTI Energy, Inc. · Jan 4, 2023
Pacira BioSciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
Pacira BioSciences, Inc. · Jan 4, 2023
Ouster Launches Digital Lidar Perception Platform Ouster Gemini
Ouster, Inc. · Jan 4, 2023
Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company
Orthofix Medical Inc. · Jan 4, 2023
Orion Adds Charles McDulin to Board of Directors
Orion Energy Systems, Inc. · Jan 4, 2023
Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of Diabetes
Oramed Pharmaceuticals Inc. · Jan 4, 2023
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
OptimizeRx Corporation · Jan 4, 2023
onsemi Silicon Carbide Power Module for Traction Inverters Selected for Hyundai Motor Group’s High Performance Electric Vehicles
ON Semiconductor Corporation · Jan 4, 2023
Online Marketplace AllSurplus Partners with Aaron Industrial Solutions to Sell Portuguese Oil Refinery
Liquidity Services, Inc. · Jan 4, 2023
OneMedNet Files Amendment to Form S-4 in Connection with its Proposed Business Combination with Data Knights Acquisition Corp.
OneMedNet Corp · Jan 4, 2023
NXP’s New i.MX 95 Family of Applications Processors Delivers Safe, Secure and Scalable AI-enabled Edge Platforms
NXP Semiconductors N.V. · Jan 4, 2023
Nuwellis, Inc. Announces Passage of Warrant Proposal
Nuwellis, Inc. · Jan 4, 2023
Nuvectis Pharma Announces Collaboration with ENGOT and GOG Foundation to Conduct the NXP800 Phase 1b Clinical Trial in ARID1A-Mutated Ova...
Nuvectis Pharma, Inc. · Jan 4, 2023
Nuvalent to Present at the 41st Annual J.P. Morgan Healthcare Conference
Nuvalent, Inc. · Jan 4, 2023
Nutex Health CEO to be a panel speaker at the 2023 McDermott and EY healthcare meeting in san francisco
Nutex Health Inc. · Jan 4, 2023
Nurix Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
Nurix Therapeutics, Inc. · Jan 4, 2023
Noodles & Company Joins Forces With BetterHelp To Promote Mental Health and Provide Up to $1 Million in Free Online Therapy
Noodles & Company · Jan 4, 2023
nLIGHT Announces Participation in 25th Annual Needham Growth Conference
nLIGHT, Inc. · Jan 4, 2023
New Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy
XOMA Royalty Corporation · Jan 4, 2023
Newegg Rings in New Year with 22nd Anniversary Sale
Newegg Commerce, Inc. · Jan 4, 2023
NerdWallet Announces 2023 Best-Of Award Winners
NerdWallet, Inc. · Jan 4, 2023
Nektar Therapeutics' President and CEO, Howard Robin, To Present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA
Nektar Therapeutics · Jan 4, 2023
Myriad Genetics to Present at 41st Annual J.P. Morgan Healthcare Conference
Myriad Genetics, Inc. · Jan 4, 2023
Moderna to Acquire OriCiro Genomics
Moderna, Inc. · Jan 4, 2023
MIMEDX Announces Commercial Launch of EPIFIX® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITED
MiMedx Group, Inc · Jan 4, 2023
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 13, 2023
Medpace Holdings, Inc. · Jan 4, 2023
Medallion Resources’ Associate ACDC Metals Ltd Receives Listing Confirmation on the ASX
Gamma Resources Ltd. · Jan 4, 2023
Masimo to Present in 41st Annual J.P. Morgan Healthcare Conference
Masimo Corporation · Jan 4, 2023
Martin Kay Named CEO of Netcapital Inc.
Netcapital Inc. · Jan 4, 2023
MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference
MacroGenics, Inc. · Jan 4, 2023
MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors
MacroGenics, Inc. · Jan 4, 2023
LifeMD Appoints Jessica Friedeman as Chief Marketing Officer to Support the Company’s Rapid Expansion into Virtual Primary Care
LifeMD, Inc. · Jan 4, 2023
Lesaka enters new employment arrangement with Steven Heilbron to June 2025
Lesaka Technologies, Inc. · Jan 4, 2023
Laser Photonics Fulfills Third Order with Same Customer for a CleanTech Laser Blasting System in the Automotive Manufacturing Segment
Laser Photonics Corporation · Jan 4, 2023
LanzaTech Founder to Take on Advisory Role to Accelerate Extension of Core Technology
LanzaTech Global, Inc. · Jan 4, 2023
Lantheus to Present at the J.P. Morgan 2023 Healthcare Conference
Lantheus Holdings, Inc. · Jan 4, 2023
Kymera Appoints Ellen Chiniara, J.D., as Chief Legal Officer and Corporate Secretary
Kymera Therapeutics, Inc. · Jan 4, 2023
Kuya Silver Acquires Right to Purchase 100% Interest In Silver Kings Joint Venture, Cobalt, Ontario
Kuya Silver Corporation · Jan 4, 2023
Kopin to Showcase Expanded Family of Lightning® OLED Microdisplays at Pepcom’s Digital Experience! During CES 2023
Kopin Corporation · Jan 4, 2023
Kodiak Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
Kodiak Sciences Inc · Jan 4, 2023
Kodiak Robotics Equips Autonomous Trucks With Ambarella AI System-on-Chip
Ambarella, Inc. · Jan 4, 2023
Kamada Announces Submission of Application to the U.S. FDA to Manufacture CYTOGAM® at the Company’s Facility in Israel
Kamada Ltd. · Jan 4, 2023
JFrog to Present at the 25th Annual Needham Growth Conference
JFrog Ltd. · Jan 4, 2023
Jasper Therapeutics Announces European Union Orphan Drug Designation for Briquilimab as a Conditioning Treatment for Patients Prior to Re...
Jasper Therapeutics, Inc. · Jan 4, 2023
IS&S ThrustSense® Autothrottle adds STC for King Air G1000 flight decks and continues strong growth in the King Air market
Innovative Solutions and Support, Inc. · Jan 4, 2023
Ironwood Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
Ironwood Pharmaceuticals, Inc. · Jan 4, 2023
Ionis to present at 41st Annual J.P. Morgan Healthcare conference
Ionis Pharmaceuticals, Inc. · Jan 4, 2023
Inter Parfums, Inc. Raises 2022 and 2023 Financial Guidance
Interparfums, Inc. · Jan 4, 2023
Intel to Report Fourth-Quarter and Full-Year 2022 Financial Results
Intel Corporation · Jan 4, 2023
Innoviz and Exwayz Collaborate on Turnkey LiDAR-based Perception Solutions for Global Customers
Innoviz Technologies Ltd. · Jan 4, 2023
Host Hotels & Resorts Completes $2.5 Billion Sustainability-Linked Credit Facility Refinancing, Maintains Pricing
Host Hotels & Resorts, Inc. · Jan 4, 2023
Homology Medicines Provides Update on pheEDIT and juMPStart Clinical Trials and Announces Expected 2023 Milestones, Including Initial Dat...
Q32 Bio Inc. · Jan 4, 2023
HeartSciences Appoints David R. Wells to its Board of Directors, an Experienced Capital Markets and Finance Executive
HeartSciences Inc. · Jan 4, 2023
Harmonic to Participate in the 25th Annual Needham Growth Conference
Harmonic Inc. · Jan 4, 2023
Hamilton Lane Closes Direct Equity Fund at Nearly $2.1 Billion in Commitments
Hamilton Lane Incorporated · Jan 4, 2023
Goodyear unveils 90% sustainable-material demonstration tire, approved for road use
The Goodyear Tire & Rubber Company · Jan 4, 2023
Geron Corporation Announces Proposed Public Offering of Common Stock
Geron Corporation · Jan 4, 2023
Geron Announces Positive Top-Line Results from IMerge Phase 3 Trial of Imetelstat in Lower Risk MDS
Geron Corporation · Jan 4, 2023
Genprex Announces Selection of Preclinical Data for Oral Presentation at 16th International Conference on Advanced Technologies & Treatme...
Genprex, Inc. · Jan 4, 2023
Genasys Inc. Secures Emergency Management and Evacuation Software Services Contract from Utah Counties
Genasys Inc. · Jan 4, 2023
Gaming and Leisure Properties, Inc. Completes Previously Announced Sale Leaseback Transaction with Bally’s for Tiverton, RI and Biloxi, M...
Gaming and Leisure Properties, Inc. · Jan 4, 2023
Galmed reports results from the Open-Label part of the ARMOR study showing improvements in histology, imaging, and biomarkers with Aramchol
Galmed Pharmaceuticals Ltd. · Jan 4, 2023
Fulton Financial Corporation Announces Dates for Fourth Quarter 2022 Earnings Release and Webcast
Fulton Financial Corporation · Jan 4, 2023
Fulton Bank Names Dara Bachman President of Fulton Private Bank
Fulton Financial Corporation · Jan 4, 2023
Fulcrum Therapeutics Provides Business Update and 2023 Outlook
Fulcrum Therapeutics, Inc. · Jan 4, 2023
Fulcrum Therapeutics Announces CEO Transition
Fulcrum Therapeutics, Inc. · Jan 4, 2023
FTAI Aviation and Unical Aviation Acquire Assets of iAero Thrust
FTAI Aviation Ltd. · Jan 4, 2023
Forward Air Corporation Expands LTL Operations with Acquisition of Land Air Express
Forward Air Corporation · Jan 4, 2023
FormFactor, Inc. to Present at the 25th Annual Needham Growth Conference
FormFactor, Inc. · Jan 4, 2023
FOREWARN Partners with Columbus REALTORS®
Red Violet, Inc. · Jan 4, 2023
Foremost Lithium Announces Receipt of Its Second $300,000 Grant from The Manitoba Mineral Development Fund (MMDF)
Foremost Clean Energy Ltd. · Jan 4, 2023
First Internet Bancorp to Announce Fourth Quarter 2022 Financial Results on Wednesday, January 25
First Internet Bancorp · Jan 4, 2023
Fathom Holdings to Participate in the 25th Annual Needham Growth Conference as Part of its Expanded Investor Relations Program Led by Gat...
Fathom Holdings Inc. · Jan 4, 2023
Farmer Bros. Co. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Farmer Brothers Company · Jan 4, 2023
EyePoint Pharmaceuticals Promotes Jay S. Duker, M.D. to President and Chief Operating Officer
EyePoint, Inc. · Jan 4, 2023
Euro Manganese Announces Submission of Environmental & Social Impact Assessment and Publication of 2022 Sustainability Report
Euro Manganese, Inc. · Jan 4, 2023
Eterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and President
Ernexa Therapeutics Inc. · Jan 4, 2023
Erasca to Present at the 41st Annual J.P. Morgan Healthcare Conference
Erasca, Inc. · Jan 4, 2023
Ensysce Biosciences Announces Successful Completion of Clinical Portion of Oral Human Abuse Potential Trial
Ensysce Biosciences, Inc. · Jan 4, 2023
Enlivex Receives Authorizations from French and Belgian Regulatory Agencies To Expand Its Phase II Sepsis Clinical Trial Into France and ...
Enlivex Ltd. · Jan 4, 2023
El Pollo Loco Dips into Indulgence with New Loco Burrito Grillers
El Pollo Loco Holdings, Inc. · Jan 4, 2023
Editas Medicine to Present at the 41st Annual J.P. Morgan Healthcare Conference
Editas Medicine, Inc. · Jan 4, 2023
Edgewise Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023
Edgewise Therapeutics, Inc. · Jan 4, 2023
Eagle Bancorp Announces Earnings Call On January 19, 2023
Eagle Bancorp, Inc. · Jan 4, 2023
Definitive Healthcare to Present at the 25th Annual Needham Growth Conference
Definitive Healthcare Corp. · Jan 4, 2023
Continental and Ambarella Partner On Assisted and Automated Driving Systems With Full Software Stack
Ambarella, Inc. · Jan 4, 2023
Context Therapeutics® Highlights 2023 Corporate Priorities and Pipeline Milestones
Context Therapeutics Inc. · Jan 4, 2023
CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of O...
CollPlant Biotechnologies Ltd. · Jan 4, 2023
Collegium Provides 2023 Financial Guidance
Collegium Pharmaceutical, Inc. · Jan 4, 2023
CME Group Reports Record Average Daily Volume of 23.3 Million Contracts Traded in 2022, an Increase of 19%
CME Group Inc. · Jan 4, 2023
Clover Health to Present at 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023
Clover Health Investments, Corp. · Jan 4, 2023
CleanSpark Releases December 2022 Bitcoin Mining Update
CleanSpark, Inc. · Jan 4, 2023
Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD
Cingulate Inc. · Jan 4, 2023
Charter to Hold Webcast to Discuss Fourth Quarter and Full Year 2022 Financial and Operating Results
Charter Communications, Inc. · Jan 4, 2023
CEVA and LG Partner to Bring Intelligent Vision Processing to Smart Home Appliances
CEVA, Inc. · Jan 4, 2023
Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation
Certara, Inc. · Jan 4, 2023
Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
Century Therapeutics, Inc. · Jan 4, 2023
Cenntro to Hold World Premiere of Three Vehicles and All Electric iChassis Series at CES
Cenntro Inc. · Jan 4, 2023